Health  Vol.2 No.4 , April 2010
Fetal loss rates after mid-trimester amniocentesis
ABSTRACT
Objective: Amniocentesis is an invasive cytogenic test traditionally associated with a 1/200 procedure–related pregnancy loss rate. Recent studies have questioned the validity of the traditionally stated rate. The purpose of this study was to document the results of second-trimes- ter genetic amniocentesis performed at our pe- rinatalogy clinic. Study Design: A retrospective review of all the amniocentesis procedures per- formed between 15 and 22 weeks of gestation on singleton pregnancies between May 2004 and December 2008 was performed. Spontaneous loss was defined as any unintentional preg- nancy loss at < 24 weeks of gestation. Setting: Zonguldak Karaelmas University, Faculty of Me- dicine, Department of Obstetrics and Gynecology. Population: Pregnant women followed at the Obstetrics Department. Methods: A retrospective review of all the amniocentesis procedures performed between May 2004 and December 2008 was performed. Main outcome measure: Pregnancy loss due to amniocentesis. Results: A total of 447 amniocentesis procedures were performed during the study period. The major indication for amniocentesis was positive maternal triple screening (44%). The mean gestational age at amniocentesis was 18.80 ± 2.70 weeks. The results of cytogenetic analyses revealed an abnormal karyotype in 19 pregnancies (4.3%), nine of which were trisomy 21. The overall spontaneous loss rate was 0.89% (n = 4). Conclusion: It would be useful for each center to investigate its own pregnancy loss rate and thereby provide a firmer basis for its policy for counseling women requesting amniocentesis. If enough such investigations were reported, a true benchmark figure could also emerge.

Cite this paper
nullArikan, I. , Harma, M. , Barut, A. , Harma, M. and Bayar, U. (2010) Fetal loss rates after mid-trimester amniocentesis. Health, 2, 315-317. doi: 10.4236/health.2010.24047.
References
[1]   Jenkins, T.M. and Wapner, R.J. (2004) Prenatal diagnosis of congenital disorders. In Creasy, R.K., Resnik, R. and Iams, J. Eds. Maternal-Fetal Medicine Principles and Practice. 5th Edtion, Philadelphia, WB Saunders, 235-280.

[2]   American College of Obstetricians and Gynecologists. (2007) Invasive prenatal testing for aneuploidy. ACOG Practice Bulletin No. 88, Obstetrics & Gynecolgy, 110, 1459-1467.

[3]   Rappaport, V.J. (2008) Prenatal diagnosis and genetic screening-integration into prenatal care. Obstetrics & Gynecology Clinics of North America, 35, 3.

[4]   Centers for Disease Control and Prevention. (1995) Chorionic villus sampling and amniocentesis: Recommendations for prenatal counseling. MMWR Recommendations and Reports, 44, 1-12.

[5]   Bornstein, E., Lenchner, E., Donnenfeld, A., Barnhard, Y., Seubert, D. and Divon, M. (2009) Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice. Journal of Perinatal Medicine, 37, 99-102.

[6]   Eddleman, K.A., Malone, F.D., Sullivan, L. et al. (2006) Pregnancy loss rates after midtrimester amniocentesis. Obstetrics & Gynecology, 108, 1067-1072.

[7]   Odibo, A.O., Gray, D.L., Dicke, J.M., Stamilio, D.M., Macones, G.A. and Crane, J.P. (2008) Revisiting the fetal loss rate after second-trimester genetic amniocentesis: A single center’s 16-year experience. Obstetrics & Gynecology, 111, 589-595.

[8]   American College of Obstetricians and Gynecologists. (2001) Prenatal diagnosis of fetal chromosomal abnormalities. ACOG Practice Bulletin, Washington (DC), ACOG, 27.

[9]   Nicolaides, K. (2007) Pregnancy loss rates after midtrimester amniocentesis. Obstetrics & Gynecology, 109(3), 780.

[10]   Wapner, R.J., Evans, M.I. and Platt, L.D. (2007) Pregnancy loss rates after midtrimester amniocentesis. Obstetrics & Gynecology, 109(3), 780.

[11]   Alfrevic, Z. and Tabor, A. (2007) Pregnancy loss rates after midtrimester amniocentesis. Obstetrics & Gynecology, 109(5), 1203-1204.

[12]   Tabor, A., Philip, J., Madsen, M., Bang, J., Obel, E.B. and Norgard-Pedersen, B. (1986) Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet, 1, 1287-1293.

[13]   Seeds, J.W. (2004) Diagnostic mid trimester amniocentesis: how safe? American Journal of Obstetrics & Gynecology, 191, 607-616.

[14]   American College of Obstetricians and Gynecologists. (2007) Invasive prenatal testing for aneuploidy. ACOG Practice Bulletin No. 88, Obstetrics & Gynecolgy, 110, 1459-1467.

[15]   Martin, J.A., Hamilton, B.E., Sutton, P.D, et al. (2007) Births: Final data for 2005. National Vital Statistics Reports, 56, 6.

 
 
Top